5 Andreas Halvorsen Adaptive Biotechnologies Trades
Andreas Halvorsen's position in Adaptive Biotechnologies is currently worth $278 Million. That's 0.91% of their equity portfolio (38th largest holding). The investor owns 19.02% of the outstanding Adaptive Biotechnologies stock. Andreas Halvorsen started to build up the position in Adaptive Biotechnologies in Q2 2019 and continued to invest until Q2 2019. Since then they sold 8.41 Million shares. The investor's estimated purchase price is $1.33 Billion, resulting in a loss of 79%.
Avg closing price
Price range
Sold 3.2% shares (-1 Million shares)
Dec 14, 2020
Avg closing price
$57.18
Price range
$57.18
-
$57.18
Sold 7.5% shares (-2.5 Million shares)
Nov 11, 2020
Avg closing price
$51.93
Price range
$51.93
-
$51.93
Sold 12.8% shares (-4.91 Million shares)
Jan 28, 2020
Avg closing price
$31.09
Price range
$31.09
-
$31.09
Increased shares by 2595.2% (+37 Million shares)
Q2 2019
Avg closing price
$44.30
Price range
$40.30
-
$48.30
New holding (+1.43 Million shares)
Jun 26, 2019
Avg closing price
-
Price range
-
-
-
